0000899243-19-000577.txt : 20190104
0000899243-19-000577.hdr.sgml : 20190104
20190104212234
ACCESSION NUMBER:		0000899243-19-000577
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20190104
FILED AS OF DATE:		20190104
DATE AS OF CHANGE:		20190104
REPORTING-OWNER:	
	OWNER DATA:	
		COMPANY CONFORMED NAME:			BRENNER LOUIS MD
		CENTRAL INDEX KEY:			0001389500
	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38268
		FILM NUMBER:		19512053
	MAIL ADDRESS:	
		STREET 1:		RADIUS HEALTH, INC.
		STREET 2:		201 BROADWAY, 6TH FLOOR
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02140
ISSUER:		
	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Allena Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001624658
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				452729920
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231
	BUSINESS ADDRESS:	
		STREET 1:		ONE NEWTON EXECUTIVE PARK
		STREET 2:		SUITE 202
		CITY:			NEWTON
		STATE:			MA
		ZIP:			02462
		BUSINESS PHONE:		617-467-4577
	MAIL ADDRESS:	
		STREET 1:		ONE NEWTON EXECUTIVE PARK
		STREET 2:		SUITE 202
		CITY:			NEWTON
		STATE:			MA
		ZIP:			02462
4
1
doc4.xml
FORM 4 SUBMISSION
    X0306
    4
    2019-01-04
    0
    
        0001624658
        Allena Pharmaceuticals, Inc.
        ALNA
    
    
        
            0001389500
            BRENNER LOUIS MD
        
        
            C/O ALLENA PHARMACEUTICALS, INC.
            ONE NEWTON EXECUTIVE PARK, SUITE 202
            NEWTON
            MA
            02462
            
        
        
            0
            1
            0
            0
            President and COO
        
    
    
        
            
                Stock Option (Right to Buy)
            
            
                7.03
            
            
                2019-01-04
            
            
            
                4
                A
                0
            
            
                
            
            
                
                    305000
                
                
                    0.00
                
                
                    A
                
            
            
                
            
            
                2029-01-03
            
            
                
                    Common Stock
                
                
                    305000
                
            
            
                
                    305000
                
            
            
                
                    D
                
            
        
    
    
        Stock option shall vest over a four-year period beginning February 1, 2019, with 25% vesting on the one-year anniversary of the vesting commencement date and the balance vesting ratably on a monthly basis over the remaining three-year period.
    
    
    
        /s/ Kevin Brennan, attorney in fact
        2019-01-04